Karo Bio: European Patent Strengthens Project for Treatment of Atherosclerosis
April 16, 2002 03:12 ET
|
Karo Bio
HUDDINGE, Sweden, April 16, 2002 (PRIMEZONE) -- Karo Bio has received a European patent for the LXR beta-receptor, which is a new important drug discovery target for treatment of...
Meridia Patient Files Class Action Lawsuit Against Abbott and Knoll According to Schiffrin & Barroway, LLP -- ABT
March 27, 2002 15:24 ET
|
Schiffrin Barroway Topaz & Kessler, LLP
BALA CYNWYD, Pa., March 27, 2002 (PRIMEZONE) -- The following statement was issued today by the law firm of Schiffrin & Barroway, LLP:
Notice is hereby given that Schiffrin & Barroway, LLP...
David Gee Joins Pharmexa as Director of Licensing
March 14, 2002 05:05 ET
|
Pharmexa A/S
HORSHOLM, Denmark, March 14, 2002 (PRIMEZONE) -- Pharmexa today announced the appointment of David Gee as Director of Licensing. David joins Pharmexa to manage the out-licensing activities of the...
Wilhelm Sonesson to Distribute Holding in Optilink to Shareholders
February 14, 2002 05:50 ET
|
Wilhelm Sonesson
MALMO, Sweden, Feb. 14, 2002 (PRIMEZONE) -- The Board of Directors of Wilh. Sonesson has decided to propose to the next Annual General Meeting, to be held April 24, 2002 in Malmo, that the holding of...
Wilhelm Sonesson: Year-End Report, January 1 - December 31, 2001 (with link)
February 14, 2002 05:37 ET
|
Wilhelm Sonesson
MALMO, Sweden, Feb. 14, 2002 (PRIMEZONE) -- Wilhelm Sonesson:
-- The Board of Directors proposes the distribution of shareholdings
in Optilink.
Full year/12 months
-- Net sales...
Karo Bio: Full Year Report 2001 - Quarterly Report, October-December 2001 (with link)
February 08, 2002 05:15 ET
|
Karo Bio
HUDDINGE, Sweden, Feb. 8, 2002 (PRIMEZONE) -- Karo Bio:
-- American Home Products became strategic partner for
atherosclerosis. The agreement may bring Karo Bio MUSD 100 in
revenues...
Solvay Group: 2001 Provisional Results (with link)
February 08, 2002 03:21 ET
|
CompanynewsGroup
BRUSSELS, Belgium, Feb. 8, 2002 (PRIMEZONE) -- Solvay (Euronext Brussels: SOLB) (Xetra: SOL)
-- Net current earnings of EUR 403 million, down 7 % from the record
level of 2000. Second half...
Karo Bio and GPC Biotech Successfully Develop Ten Assays for Novel Anibacterial Targets
February 06, 2002 04:13 ET
|
Karo Bio
MUNICH, Germany, Feb. 6, 2002 (PRIMEZONE) -- Karo Bio USA, Inc., a wholly owned subsidiary of Karo Bio AB, and GPC Biotech AG (Frankfurt Stock Exchange: GPC) today announced that their technology...
Dimension Supplies Data Storage for AstraZeneca's Research
January 30, 2002 07:10 ET
|
Dimension
BROMMA, Sweden, Jan. 30, 2002 (PRIMEZONE) -- When the pharmaceutical company AstraZeneca decided to consolidate its storage of research data, the job of supplying the new data storage solution went...
atugen AG Signs Target Validation Agreement with UCSF
January 23, 2002 03:50 ET
|
atugen AG
BERLIN, Germany, Jan. 23, 2002 (PRIMEZONE) -- atugen AG, today announced the signing of an agreement with the University of California, San Francisco to utilize atugen's technology to validate the...